Assistant Prof @BCMHouston. Non-malignant Hematologist. Fellowship @OSUCCC_James. IM Residency @UTSWInternalMed '18. @UMKCmedschool ‘15. Tweets are my own.
Houston, TX
Joined June 2020
- Tweets192
- Following366
- Followers286
- Likes899
Thrilled to (safely) ring in my last Ash-a-Palooza as a trainee with my wonderful co-fellows from @OSUHematology! #ASHTrainee #ASH21 @ASH_hematology
Excellent talk on MACE in iTTP by Max Brodsky @BloodClotDoc
⭐️MACE occurs earlier in iTTP surv compared to gen pop
⭐️MACE ⬆️ in iTTP surv than those w/ traditional risk factors like CAD/PAD
⭐️Close f/u and mgmt of CV risk factors is needed in these pts #ISTH2021
Still room for improvement to prevent acute episodes and long term sequelae in our patients! @ttpdoc @BloodClotDoc
Eculizumab discontinuation appears safe in patients without rare variants in complement genes. Patients with mutations may need closer monitoring if undergoing trial of discontinuation and I would still be hesitant in those with Factor H mutations
ashpublications.org/blood/ar…
Anticoagulation therapy for splanchnic vein thrombosis is associated with vein recanalization - bleeding rates were not elevated in those receiving treatment per this meta-analysis just published in @BloodJournal @NicolettaRivaMD
ashpublications.org/blood/ar…
Excellent study by Coppo and colleagues: triplet therapy with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated #TTP in @BloodJournal
#hemetwitter #TMA
ashpublications.org/blood/ar…
Great algorithm/pathway for evaluating #TMA in #pregnancy from the International Working Group on pregnancy-related TMAs. #ASH20 @ASH_hematology
Honored to be recognized by @ASH_hematology with an Abstract Achievement Award! Check out “CV disease is a leading cause of death in TTP survivors” on 12/6 at 12:15pm. Big thanks to mentors Spero Cataland @OSUCCC_James and Shruti Chaturvedi @HopkinsMedicine for their support
Check out our Poster @ASNKidney #KidneyWk Amazing collab w @OSUCCC_James Hematology, @OSUNephrology and @OSUPathRes. Does kidney histology predict complement mutation status or renal response in #aHUS? #TMA asn.apprisor.org/epsAbstract…
Glycoproteins VI is a predictor of major bleeding in suspected HIT patients. Interesting implications for intensity of AC treatment while awaiting confirmatory testing, esp w intermediate probability 4T scores
ashpublications.org/bloodadv…
Excellent figure on differential dx and mgmt of #TTP in pregnancy from recent How I Treat in @BloodJournal
A "How I treat" article on management of pregnancy in women with congenital and acquired #TTP has been accepted by Blood. Only the submitted manuscript version is currently available. It requires personal or institutional subscription to Blood to access. tinyurl.com/yy2tzetj
Nice schematic highlighting a 4 step risk adapted approach to #DOACs vs LMWH in cancer assoc #VTE #thrombosis by Dr. @MarcCarrier1 and Dr. Tzu-fei Wang
ashpublications.org/blood/ar…
Latest in @BloodAdvances: Real world data of #Caplacizumab in #TTP confirms treatment efficacy and supports front line use ashpublications.org/bloodadv…
